secwatch.observer — SEC 8-K summary
======================================

Issuer:     AYTU BIOPHARMA, INC (AYTU)
CIK:        0001385818
Form:       8-K
Filed at:   2023-05-01T23:59:59+00:00
Accession:  0001558370-23-007404
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aytu BioPharma subleases 22,909 sq ft of manufacturing facility to AMTMS; to expand to entire facility by Dec 2024
--------------------------------------------------------------------------------

- Subleases 22,909 sq ft (~30%) of Grand Prairie, TX facility to AMTMS; base rent $20,045/mo through Dec 2023, then $21,000/mo until expansion.
- Expansion to entire 77,112 sq ft facility by Dec 31, 2024; rent rises to $70,686/mo. Security deposit of $90,731.
- CEO says sublease reduces monthly operating expenses, supports margin improvement for ADHD products; longer-term plan to transfer manufacturing to contract manufacturer.
- AMTMS is a new CMO; will use facility for nutraceutical and pharmaceutical manufacturing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1385818/000155837023007404/0001558370-23-007404-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1385818/000155837023007404/aytu-20230427x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-007404

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer